Skip to main content
NCBI home page
Journal of Clinical Pathology. Supplement (Association of Clinical Pathologists) logoLink to Journal of Clinical Pathology. Supplement (Association of Clinical Pathologists)
. 1973;5:26–31. doi: 10.1136/jcp.s1-5.1.26

Classification of lipoproteins and lipoprotein disorders.

B Lewis
PMCID: PMC1436097  PMID: 4354845

Full text

PDF
26

Images in this article

29Fig
on p.29

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ANTONIS A., BERSOHN I. Serum-triglyceride levels in South African Europeans and Bantu and in ischaemic heart-disease. Lancet. 1960 May 7;1(7132):998–1002. doi: 10.1016/s0140-6736(60)90886-2. [DOI] [PubMed] [Google Scholar]
  2. Alaupovic P. Apoliproproteins and lipoproteins. Atherosclerosis. 1971 Mar-Apr;13(2):141–146. doi: 10.1016/0021-9150(71)90018-9. [DOI] [PubMed] [Google Scholar]
  3. Alaupovic P., Lee D. M., McConathy W. J. Studies on the composition and structure of plasma lipoproteins. Distribution of lipoprotein families in major density classes of normal human plasma lipoproteins. Biochim Biophys Acta. 1972 Apr 18;260(4):689–707. [PubMed] [Google Scholar]
  4. Albers J. J., Scanu A. M. Isoelectric fractionation and characterization of polypeptides from human serum very low density lipoproteins. Biochim Biophys Acta. 1971 Apr 27;236(1):29–37. doi: 10.1016/0005-2795(71)90145-0. [DOI] [PubMed] [Google Scholar]
  5. BERG K. A NEW SERUM TYPE SYSTEM IN MAN--THE LP SYSTEM. Acta Pathol Microbiol Scand. 1963;59:369–382. doi: 10.1111/j.1699-0463.1963.tb01808.x. [DOI] [PubMed] [Google Scholar]
  6. Beaumont J. L., Carlson L. A., Cooper G. R., Fejfar Z., Fredrickson D. S., Strasser T. Classification of hyperlipidaemias and hyperlipoproteinaemias. Bull World Health Organ. 1970;43(6):891–915. [PMC free article] [PubMed] [Google Scholar]
  7. Billimoria J. D., Fahmy M. F., Jepson E. M., Maclagan N. F. The use of the esterified fatty acid index in the classification and quantitation of hyperlipoproteinaemias. Atherosclerosis. 1971 Nov-Dec;14(3):359–374. doi: 10.1016/0021-9150(71)90064-5. [DOI] [PubMed] [Google Scholar]
  8. Boberg J., Carlson L. A., Freyschuss U., Lassers B. W., Wahlqvist M. L. Splanchnic secretion rates of plasma triglycerides and total and splanchnic turnover of plasma free fatty acids in men with normo- and hypertriglyceridaemia. Eur J Clin Invest. 1972 Nov;2(6):454–466. doi: 10.1111/j.1365-2362.1972.tb00677.x. [DOI] [PubMed] [Google Scholar]
  9. Brown W. V., Levy R. I., Fredrickson D. S. Studies of the proteins in human plasma very low density lipoproteins. J Biol Chem. 1969 Oct 25;244(20):5687–5694. [PubMed] [Google Scholar]
  10. CARLSON L. A. Chromatographic separation of serum lipoproteins on glass powder columns. Description of the method and some applications. Clin Chim Acta. 1960 Jul;5:528–538. doi: 10.1016/0009-8981(60)90064-4. [DOI] [PubMed] [Google Scholar]
  11. Carlson L. A., Böttiger L. E. Ischaemic heart-disease in relation to fasting values of plasma triglycerides and cholesterol. Stockholm prospective study. Lancet. 1972 Apr 22;1(7756):865–868. doi: 10.1016/s0140-6736(72)90738-6. [DOI] [PubMed] [Google Scholar]
  12. Carlson L. A., Kolmodin-Hedman B. Hyper- -lipoproteinemia in men exposed to chlorinated hydrocarbon pesticides. Acta Med Scand. 1972 Jul-Aug;192(1-2):29–32. doi: 10.1111/j.0954-6820.1972.tb04773.x. [DOI] [PubMed] [Google Scholar]
  13. Carlson L. A. Plasma or patient, paper electrophoresis or physician? the four-P problem in classification of hyperlipidaemia. Atherosclerosis. 1970 Sep-Oct;12(2):181–183. doi: 10.1016/0021-9150(70)90094-8. [DOI] [PubMed] [Google Scholar]
  14. Carter C. O., Slack J., Myant N. B. Genetics of hyperlipoproteinaemias. Lancet. 1971 Feb 20;1(7695):400–401. doi: 10.1016/s0140-6736(71)92238-0. [DOI] [PubMed] [Google Scholar]
  15. Christakis G., Rinzler S. H., Archer M., Winslow G., Jampel S., Stephenson J., Friedman G., Fein H., Kraus A., James G. The anti-coronary club. A dietary approach to the prevention of coronary heart disease--a seven-year report. Am J Public Health Nations Health. 1966 Feb;56(2):299–314. doi: 10.2105/ajph.56.2.299. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Cramp D. G., Robertson G. The fluorometric assay of triglyceride by a semiautomated method. Anal Biochem. 1968 Oct 24;25(1):246–251. doi: 10.1016/0003-2697(68)90097-3. [DOI] [PubMed] [Google Scholar]
  17. Dayton S., Pearce M. L., Goldman H., Harnish A., Plotkin D., Shickman M., Winfield M., Zager A., Dixon W. Controlled trial of a diet high in unsaturated fat for prevention of atherosclerotic complications. Lancet. 1968 Nov 16;2(7577):1060–1062. doi: 10.1016/s0140-6736(68)91531-6. [DOI] [PubMed] [Google Scholar]
  18. Fredrickson D. S., Levy R. I., Lees R. S. Fat transport in lipoproteins--an integrated approach to mechanisms and disorders. N Engl J Med. 1967 Feb 2;276(5):273–concl. doi: 10.1056/NEJM196702022760507. [DOI] [PubMed] [Google Scholar]
  19. Fredrickson D. S., Levy R. I., Lindgren F. T. A comparison of heritable abnormal lipoprotein patterns as defined by two different techniques. J Clin Invest. 1969 Nov;47(11):2446–2457. doi: 10.1172/JCI105927. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Fredrickson D. S. Plasma lipoproteins: micellar models and mutants. Trans Assoc Am Physicians. 1969;82:68–86. [PubMed] [Google Scholar]
  21. Glueck C. J., Levy R. I., Fredrickson D. S. Immunoreactive insulin, glucose tolerance, and carbohydrate inducibility in types II, 3, IV, and V hyperlipoproteinemia. Diabetes. 1969 Nov;18(11):739–747. doi: 10.2337/diab.18.11.739. [DOI] [PubMed] [Google Scholar]
  22. Goldman J. A., Glueck C. J., Abrams N. R., Steiner P., Herman J. H. Musculoskeletal disorders associated with type-IV hyperlipoproteinaemia. Lancet. 1972 Sep 2;2(7775):449–452. doi: 10.1016/s0140-6736(72)91852-1. [DOI] [PubMed] [Google Scholar]
  23. Greenhalgh R. M., Rosengarten D. S., Mervart I., Lewis B., Calnan J. S., Martin P. Serum lipids and lipoproteins in peripheral vascular disease. Lancet. 1971 Oct 30;2(7731):947–950. doi: 10.1016/s0140-6736(71)90269-8. [DOI] [PubMed] [Google Scholar]
  24. HAVEL R. J., GORDON R. S., Jr Idiopathic hyperlipemia: metabolic studies in an affected family. J Clin Invest. 1960 Dec;39:1777–1790. doi: 10.1172/JCI104202. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Havel R. J., Kane J. P., Balasse E. O., Segel N., Basso L. V. Splanchnic metabolism of free fatty acids and production of triglycerides of very low density lipoproteins in normotriglyceridemic and hypertriglyceridemic humans. J Clin Invest. 1970 Nov;49(11):2017–2035. doi: 10.1172/JCI106422. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. KOERSELMAN H. B., LEWIS B., PILKINGTON T. R. The effect of venous occlusion on the level of serum cholesterol. J Atheroscler Res. 1961 Jan-Feb;1:85–88. doi: 10.1016/s0368-1319(61)80058-6. [DOI] [PubMed] [Google Scholar]
  27. LEES R. S., HATCH F. T. Sharper separation of lipoprotein species by paper electrophoresis in albumin-containing buffer. J Lab Clin Med. 1963 Mar;61:518–528. [PubMed] [Google Scholar]
  28. Langer T., Levy R. I. Acute muscular syndrome associated with administration of clofibrate. N Engl J Med. 1968 Oct 17;279(16):856–858. doi: 10.1056/NEJM196810172791604. [DOI] [PubMed] [Google Scholar]
  29. Langer T., Strober W., Levy R. I. The metabolism of low density lipoprotein in familial type II hyperlipoproteinemia. J Clin Invest. 1972 Jun;51(6):1528–1536. doi: 10.1172/JCI106949. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Levy R. I., Bilheimer D. W., Eisenberg S. The structure and metabolism of chylomicrons and very low density lipoproteins (VLDL). Biochem Soc Symp. 1971;(33):3–17. [PubMed] [Google Scholar]
  31. Lewis B., Myant N. B. Studies in the metabolism of cholesterol in subjects with normal plasma cholesterol levels and in patients with essential hypercholesterolaemia. Clin Sci. 1967 Apr;32(2):201–213. [PubMed] [Google Scholar]
  32. Matthews R. J. Type 3 and IV familial hyperlipoproteinemia. Evidence that these two syndromes are different phenotypic expressions of the same mutant gene(s). Am J Med. 1968 Feb;44(2):188–199. doi: 10.1016/0002-9343(68)90150-2. [DOI] [PubMed] [Google Scholar]
  33. Miettinen M., Turpeinen O., Karvonen M. J., Elosuo R., Paavilainen E. Effect of cholesterol-lowering diet on mortality from coronary heart-disease and other causes. A twelve-year clinical trial in men and women. Lancet. 1972 Oct 21;2(7782):835–838. doi: 10.1016/s0140-6736(72)92208-8. [DOI] [PubMed] [Google Scholar]
  34. NICHOLS A. V., SMITH L. EFFECT OF VERY LOW-DENSITY LIPOPROTEINS ON LIPID TRANSFER IN INCUBATED SERUM. J Lipid Res. 1965 Apr;6:206–210. [PubMed] [Google Scholar]
  35. SHAPER A. G., JONES K. W. Serum-cholesterol, diet, and coronary heart-disease in Africans and Asians in Uganda. Lancet. 1959 Oct 10;2(7102):534–537. doi: 10.1016/s0140-6736(59)91777-5. [DOI] [PubMed] [Google Scholar]
  36. Simons L., Wahab S., Chait A., Krikler D. M., Lewis B. A study of hyper-beta- and hyperpre-beta-lipoproteinaemia. Br Heart J. 1972 Sep;34(9):960–960. [PMC free article] [PubMed] [Google Scholar]
  37. Spritz N., Mishkel M. A. Effects of dietary fats on plasma lipids and lipoproteins: an hypothesis for the lipid-lowering effect of unsaturated fatty acids. J Clin Invest. 1969 Jan;48(1):78–86. doi: 10.1172/JCI105976. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Steinber D. Some observations on hyperlipoproteinemias and their classification. Circulation. 1972 Feb;45(2):247–251. doi: 10.1161/01.cir.45.2.247. [DOI] [PubMed] [Google Scholar]
  39. Stone M. C., Thorp J. M., Mills G. L., Dick T. B. Comparison of membrane filtration and nephelometry with analytical ultracentrifugation, for the quantitative analysis of low density lipoprotein fractions. Clin Chim Acta. 1970 Dec;30(3):809–828. doi: 10.1016/0009-8981(70)90279-2. [DOI] [PubMed] [Google Scholar]
  40. Werner M., Jones A. L. Characterization of electrophoretic lipoprotein fractions: immunochemical and electron microscopic studies. Clin Chem. 1972 Jun;18(6):534–538. [PubMed] [Google Scholar]
  41. Wood P. D., Stern M. P., Silvers A., Reaven G. M., von der Groeben J. Prevalence of plasma lipoprotein abnormalities in a free-living population of the Central Valley, California. Circulation. 1972 Jan;45(1):114–126. doi: 10.1161/01.cir.45.1.114. [DOI] [PubMed] [Google Scholar]
  42. de Gennes J. L. Les hyperlipidémies idiopathiques. Proposition d'une classification simplifiée. Presse Med. 1971 Apr 10;79(18):791–795. [PubMed] [Google Scholar]

Articles from Journal of Clinical Pathology. Supplement (Ass. Clin. Path.) are provided here courtesy of BMJ Publishing Group

RESOURCES